
Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.

Results presented at the European Society for Medical Oncology meeting could help separate Roche’s medicine from similar hormone-degrading drugs for breast tumors.
See how a mechanistic QSP platform captures disease progression and treatment response to enable better…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
The pharmaceutical (pharma) and biopharmaceutical (biopharma) industries play a crucial role in healthcare by developing drugs and therapies to treat…
Checkpoint inhibitor therapies (NIH) On October 1, 2018, the The Nobel Assembly at the Karolinska Institute announced that it had…
Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on…
Just two acquisitions in the first quarter, that of Intra-Cellular Therapies and IDRx, crossed the $1 billion mark, a notable…
Sign in to your account